Pavel Gerasimov

Biography

  Novartis Dates Employed2016 – Present   Employment Duration1 yr LocationNational   • Elaboration, management and update of Market Access strategies for Novartis Solid Tumors portfolio; • Collection and analysis of all regulatory changes related to pricing and reimbursement of Novartis Solid Tumors portfolio;  • Preparation of all necessary documents for applying for reimbursement of Novartis Solid Tumors portfolio (EDL, ONLS, 7N, Trade name list, Regional reimbursement lists), Standards of Treatment, Treatment guidelines, OMI Tariffs (DRGs); • Development of relationships with relevant regional and federal payers in oncology (government and territory fund of obligatory medical insurance officials, healthcare authorities, federal and regional KOLs) for inclusion of Novartis Solid Tumors portfolio in formularies, DRGs, Standards of Treatment, Treatment guidelines in cooperation with Commercial KAMs and Sales Managers; • Provision of strong support and training for KAMs and Sales Managers on new Market Access data about Novartis Solid Tumors portfolio, HEOR and changes in reimbursement and regulatory environment; • Consistent stakeholder engagement and raising payers awareness by educational programs for healthcare authorities on federal and regional level in collaboration with KAMs; • Communication of any data that may impact reimbursement activities on federal and regional level with Solid Tumors BF and coordination of further Market Access activities on cross-functional basis (marketing – medical – market access); • Analysis of main gaps in current model of oncology drug provision and implementation of Patient Access Models to bridge those gaps and overcome the main hurdles that hold down business growth.

Research Interest

 Clinical Research, Business Management, Development